Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker
Véronique Hofman, Christelle Bonnetaud, Marius Ilié et al. · Clinical Cancer Research · 2010
PURPOSE: Pathologic TNM staging is currently the best prognostic factor for non-small cell lung carcinoma (NSCLC). However, even in early-stage NSCLC, the recurrence rates after surgery range from 25% to 50%. The preoperative detection of circulating tumor cells (CTC) could be useful to tailor new therapeutic strategies in NSCLC. We assessed the presence of CTC in NSCLC patients undergoing surgery, using cytologic analyses, after their isolation by size of epithelial tumor cells (ISET method). The presence and the number of CTCs were considered and correlated with clinicopathologic parameters including patient follow-up. EXPERIMENTAL DESIGN: Of the 247 blood samples tested, 208 samples were from patients with resectable NSCLC and 39 from healthy subjects. The mean follow-up was 24 months. An image of detected cells with presumably nonhematologic features [initially defined as "circulating nonhematologic cells" (CNHC)] was recorded. The presence of CNHC was assessed blindly and independently by 10 cytopathologists, using cytologic criteria of malignancy on stained filters. The count of detected CNHCs was made for each filter. RESULTS: One hundred two of 208 (49%) patients showed CNHCs corresponding to CNHC with malignant cytopathologic features in 76 of 208 (36%) cases. CNHCs were not detected in the control group. A level of 50 or more CNHCs corresponding to the third quartile was associated with shorter overall and disease-free-survival, independently of disease staging, and with a high risk of recurrence and death in early-stage I + II-resectable NSCLC. CONCLUSION: A high percentage of NSCLC patients show preoperative detection of CNHC by the ISET method. The presence and level of 50 or more CNHCs are associated with worse survival of patients with resectable NSCLC.
Cited by 308 works. doi:10.1158/1078-0432.ccr-10-0445 Open-access PDF
Authors
- Véronique Hofman
- Christelle Bonnetaud
- Marius Ilié
- Philippe R. Vielh
- Jean-Michel Vignaud
- Jean François Fléjou
- Sylvie Lantuéjoul
- Éric Piaton
- Nadine Mourad
- Catherine Butori
- Éric Selva
- M. Poudenx
- Stéphanie Sibon
- Sabrina Kelhef
- Nicolas Vénissac
- Jean‐Philippe Jaïs
- Jérôme Mouroux
- Thierry Jo Molina
- Véronique Hofman
References
- The Measurement of Observer Agreement for Categorical Data
- Cancer Statistics, 2008
- Revisions in the International System for Staging Lung Cancer
- Detection of Mutations in EGFR in Circulating Lung-Cancer Cells
- Isolation by Size of Epithelial Tumor Cells
- Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience
- Circulating tumor cells (CTC) detection: Clinical impact and future directions
- Prognosis of 6644 resected non-small cell lung cancers in Japan: A Japanese lung cancer registry study
- Resting and activated endothelial cells are increased in the peripheral blood of cancer patients
- Quantification of Free Circulating DNA As a Diagnostic Marker in Lung Cancer